Skip to main content
. 2022 Jan 5;75(6):1031–1036. doi: 10.1093/cid/ciac004

Table 1.

Demographics and Medical Comorbidities of Candida BSI Case Patients and Frequency-Matched Control Patients

Characteristic Candida Cases N = 626 n (%) Matched Controls N = 6269 n (%)
Age, median (IQR) years 58 (46–66) 61 (52–70)
Sex
 Female 268 (42.8) 2952 (47.1)
Race
 White 437 (69.8) 4603 (73.4)
 Black 146 (23.3) 1343 (21.4)
 Other 43 (6.9) 323 (5.2)
Hierarchical categoriesa of medical conditions (hierarchical rank)
 Leukemia, myelodysplastic syndrome, bone marrow transplant (1) 143 (22.8) 1416 (22.6)
 Central venous catheter, dialysis catheter (2) 338 (54.0) 3379 (53.9)
 Solid organ transplant (3) 3 (0.5) 30 (0.5)
 Lymphoma, metastatic cancer (4) 40 (6.4) 408 (6.5)
 Fistula, pancreatitis, abdominal surgery (5) 35 (5.6) 368 (5.8)
 Bacteremia (6) 24 (3.8) 233 (3.7)
 Cardiac surgery (7) 8 (1.3) 80 (1.3)
 Chronic liver disease (8) 18 (2.9) 189 (3.0)
 Drug abuse (9) 6 (1.0) 60 (1.0)
 Acute renal failure (10) 11 (1.7) 107 (1.7)

The 1:10 frequency-match distribution of the hierarchical categories is not exact due to patients excluded due death occurring within 24 hours of admission.

Abbreviations: BSI, bloodstream infection; IQR, interquartile range.

Candida BSI cases and frequency-matched controls were placed into the first risk factor category for which they had a qualifying diagnosis. They remained in that category without regards to subsequent risk factors. Finally, for the control candidates, if they did not match with a Candida BSI case patient, they could not be bumped to a risk factor category lower in the hierarchy.